Weldon Richardson, PA
Medical · Idaho Falls, IDNPI 1629351614
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,955 of the $8,256 with a category attached, or 84.2%. 20 manufacturers reported payments, led by Nalu Medical, Inc. at 24.7% of the total. Reporting peaked in 2023 at $2,956 and has fallen 57.7% since, to $1,249 in 2025. Among medical clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$2K
- Boston Scientific$2K
- AbbVie$2K
- Medtronic$1K
- Abbott$541
- Lilly USA, LLC$185
- plus $692 from 14 others
What the payments were for
- Travel & lodging$1,30216%
- Food & beverage$6,95584%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 41 | $2,037 |
| Boston Scientific | 136 | $1,904 |
| AbbVie | 95 | $1,787 |
| Medtronic | 81 | $1,111 |
| Abbott | 42 | $541 |
| Lilly USA, LLC | 18 | $185 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $124 |
| Nevro Corp. | 3 | $115 |
| Pfizer | 7 | $101 |
| Vertex | 3 | $84 |
| Averitas Pharma Inc. | 3 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| GRT US Holding, Inc. | 2 | $22 |
| Curonix LLC | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| SPR Therapeutics, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,256 in reported general payments places this provider in the 95th percentile of 265 medical providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 557 | $35,543 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 869 | $26,038 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 984 | $24,061 |
| Nurtec OdtRimegepant Sulfate | 15 | $23,909 |
| Buprenorphine | 74 | $21,380 |
| OxycontinOxycodone Hcl | 39 | $18,674 |
| RelistorMethylnaltrexone Bromide | 16 | $18,385 |
| QuliptaAtogepant | 14 | $13,492 |
| MovantikNaloxegol Oxalate | 33 | $12,997 |
| Gabapentin | 614 | $11,677 |
| Oxycodone Hcl | 317 | $8,530 |
| LinzessLinaclotide | 11 | $5,844 |
| Celecoxib | 135 | $5,670 |
| Fentanyl | 24 | $5,223 |
| Tizanidine Hcl | 364 | $3,293 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $101 | $23,90915 claims |
| AbbVieQulipta, Linzess | $1,787 | $19,33625 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $124 | $18,38516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 265 medical providers in Idaho.
Other medical in Idaho Falls
- Jed BartschiIdaho Falls$11K
- Wade ChristensenIdaho Falls$8K
- Joshua HansenIdaho Falls$8K
- Cameron FrenchIdaho Falls$5K
- Brandon LarsenIdaho Falls$5K
- Rebecca WestergardIdaho Falls$4K
- Shelley DavisIdaho Falls$4K
- Alyssa JenkinsIdaho Falls$3K
- William UlrichIdaho Falls$2K
- Ivy HansenIdaho Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.